Teva Pharmaceutical Industries Limited Stock TEL AVIV STOCK EXCHANGE
Equities
IL0006290147
Pharmaceuticals
Sales 2024 * | 15.86B 59.44B | Sales 2025 * | 16.4B 61.46B | Capitalization | 15.64B 58.63B |
---|---|---|---|---|---|
Net income 2024 * | 1.54B 5.77B | Net income 2025 * | 1.44B 5.41B | EV / Sales 2024 * | 1.92 x |
Net Debt 2024 * | 14.82B 55.54B | Net Debt 2025 * | 12.25B 45.91B | EV / Sales 2025 * | 1.7 x |
P/E ratio 2024 * |
11.1
x | P/E ratio 2025 * |
10.3
x | Employees | - |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 89.71% |
Latest transcript on Teva Pharmaceutical Industries Limited
Managers | Title | Age | Since |
---|---|---|---|
Richard Francis
CEO | Chief Executive Officer | 55 | 22-12-31 |
Eli Kalif
DFI | Director of Finance/CFO | 51 | 19-12-21 |
Eric Hughes
CTO | Chief Tech/Sci/R&D Officer | - | 22-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
Gerald Lieberman
BRD | Director/Board Member | 77 | 15-08-31 |
Janet Vergis
BRD | Director/Board Member | 60 | 20-06-08 |
Sol Barer
CHM | Chairman | 76 | 14-12-31 |
1st Jan change | Capi. | |
---|---|---|
+26.09% | 661B | |
+26.74% | 566B | |
-6.53% | 352B | |
+18.84% | 332B | |
+3.82% | 283B | |
+13.43% | 231B | |
+4.71% | 200B | |
-9.53% | 195B | |
-4.14% | 145B |